Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease

Eugene Hone, Florence Lim, Ian Martins

Research output: Chapter in Book/Conference paperChapter

Abstract

Lipidomics and genomics studies have made it very clear that lipids and their
metabolism are central in AD pathogenesis. This review has described many of the lipid-related changes that occur in AD, demonstrating the wide range of such changes and, in some cases, listing potential therapeutic treatments. Reducing the risk of AD will involve dietary changes and healthy lifestyles that can reduce the risk of dyslipidaemia, insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation, which are all known risk factors for AD. Despite the many studies on the influence of the APOE 휀4 allele on Aβ aggregation, binding, and clearance, the overall pathological effect of this allele is still not known. Further studies will consolidate these
findings and hopefully clarify which changes in lipid metabolism are most relevant in AD pathogenesis. It is hoped this will pave the way towards effective treatments, whilst highlighting the importance of preventing dyslipidaemia.
Original languageEnglish
Title of host publicationNeurodegeneration and Alzheimer's Disease
Place of PublicationLondon
PublisherJohn Wiley & Sons
Chapter7
Pages189-231
Edition1
ISBN (Print)9781119356783
Publication statusPublished - 1 May 2019

Fingerprint Dive into the research topics of 'Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease'. Together they form a unique fingerprint.

  • Cite this

    Hone, E., Lim, F., & Martins, I. (2019). Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. In Neurodegeneration and Alzheimer's Disease (1 ed., pp. 189-231). John Wiley & Sons.